HPG
Harvest Portfolios Group Portfolio holdings
AUM
$4.3B
1-Year Est. Return
16.34%
1 Year Est. Return
+16.34%
AUM
$3.39B
AUM Growth
+$387M
(+13%)
Holding
245
Top Buys
| 1 | +$72.4M | |
| 2 | +$54.5M | |
| 3 | +$39.8M | |
| 4 |
NVIDIA
NVDA
|
+$30.3M |
| 5 |
Palantir
PLTR
|
+$25.3M |
Top Sells
| 1 | +$24.5M | |
| 2 | +$7.44M | |
| 3 | +$6.52M | |
| 4 |
Telus
TU
|
+$5.65M |
| 5 |
Boston Scientific
BSX
|
+$3.29M |
Sector Composition
| 1 | Healthcare | 34.85% |
| 2 | Technology | 22.06% |
| 3 | Financials | 6.11% |
| 4 | Consumer Discretionary | 4.53% |
| 5 | Communication Services | 4.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
iShares 20+ Year Treasury Bond ETF
TLT
$48.2B
| $331M | 9.78% |
3,638,683
+599,149
|
|
||
2
iShares 7-10 Year Treasury Bond ETF
IEF
$38.6B
| $138M | 4.07% |
1,443,149
+157,184
|
|
||
3
Eli Lilly
LLY
$827B
| $104M | 3.08% |
126,155
+3,263
|
|
||
|
4
NVIDIA
NVDA
$4.58T
| $104M | 3.06% |
954,984
+279,296
|
|
||
5
UnitedHealth
UNH
$294B
| $78.9M | 2.33% |
150,694
+14,061
|
|
||
6
Microsoft
MSFT
$3.69T
| $77M | 2.28% |
205,207
+47,292
|
|
||
7
Strategy Inc
MSTR
$69.5B
| $72.4M | 2.14% |
+251,295
|
|
||
8
Elevance Health
ELV
$70.6B
| $62.1M | 1.83% |
142,721
+1,573
|
|
||
9
AstraZeneca
AZN
$262B
| $60.6M | 1.79% |
823,961
+9,883
|
|
||
10
Bristol-Myers Squibb
BMY
$95B
| $60.1M | 1.78% |
985,650
+53,005
|
|
||
11
Abbott
ABT
$220B
| $58.2M | 1.72% |
439,005
-14,773
|
|
||
12
Amgen
AMGN
$172B
| $57.5M | 1.7% |
184,560
-20,931
|
|
||
13
Johnson & Johnson
JNJ
$450B
| $57.2M | 1.69% |
344,702
-147,763
|
|
||
14
Merck
MRK
$214B
| $56.4M | 1.67% |
628,424
+86,268
|
|
||
15
Novartis
NVS
$242B
| $56.1M | 1.66% |
503,638
-26,702
|
|
||
16
AbbVie
ABBV
$387B
| $56M | 1.65% |
267,258
-35,530
|
|
||
17
Zoetis
ZTS
$53B
| $55.3M | 1.64% |
336,138
+20,547
|
|
||
18
Medtronic
MDT
$118B
| $55.1M | 1.63% |
613,690
-31,355
|
|
||
|
19
Boston Scientific
BSX
$148B
| $54.8M | 1.62% |
543,368
-32,607
|
|
||
20
Regeneron Pharmaceuticals
REGN
$69.1B
| $52.6M | 1.55% |
82,924
+11,555
|
|
||
21
Stryker
SYK
$136B
| $52.6M | 1.55% |
141,281
-1,365
|
|
||
22
Danaher
DHR
$148B
| $50.9M | 1.5% |
248,049
+22,200
|
|
||
23
Thermo Fisher Scientific
TMO
$215B
| $49.6M | 1.47% |
99,740
+414
|
|
||
24
Vanguard Long-Term Treasury ETF
VGLT
$10.1B
| $48.1M | 1.42% |
834,205
+4,578
|
|
||
25
Intuitive Surgical
ISRG
$199B
| $48M | 1.42% |
96,823
-52
|
|